6
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      QUALITATIVE AND QUANTITATIVE MUSCLE ULTRASOUND CHANGES IN COVID-19 RELATED ARDS PATIENTS

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background & Aims

          Severe forms of COVID-19 are associated with systemic inflammation and hypercatabolism. We compared the time course of the size and quality of both rectus femoris and diaphragm muscles between critically-ill, COVID-19 survivors and non-survivors, and explored the correlation between the change in muscles size and quality with the amount of nutritional support delivered and the cumulative fluid balance.

          Methods

          Prospective observational study in the general ICU of a tertiary care hospital for COVID-19. The right rectus femoris cross-sectional area and the right diaphragm thickness, as well as their echodensities were assessed within 24 hours from ICU admission and on day 7. Anthropometric and biochemical data, respiratory mechanics and gas exchange, daily fluid balance and the amount of calories and proteins administered were recorded.

          Results

          28 patients were analysed (age 65±10 years, 80% males, BMI 30.0±7.8). Rectus femoris and diaphragm sizes were significantly reduced at day 7 (-26.1 [-37.8;-15.2] and -29.2 [-37.8;-19.6]%, respectively) and this reduction was significantly higher in non-survivors. Both rectus femoris and diaphragm echodensity were significantly increased at day 7, with a significantly higher increase in non-survivors. The change in both rectus femoris and diaphragm size at day 7 was related to the cumulative protein deficit (R=0.664, p<0.001 and R=0.640, p<0.001, respectively), while the change in rectus femoris and diaphragm echodensity was related to the cumulative fluid balance (R=0.734, p<0.001 and R=0.646, p<0.001, respectively)

          Conclusions

          Early changes in muscle size and quality seem related to the outcome of critically-ill, COVID-19 patients, and be influenced by nutritional and fluid management strategies.

          Related collections

          Most cited references65

          • Record: found
          • Abstract: found
          • Article: not found

          Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report

          Abstract Background Coronavirus disease 2019 (Covid-19) is associated with diffuse lung damage. Glucocorticoids may modulate inflammation-mediated lung injury and thereby reduce progression to respiratory failure and death. Methods In this controlled, open-label trial comparing a range of possible treatments in patients who were hospitalized with Covid-19, we randomly assigned patients to receive oral or intravenous dexamethasone (at a dose of 6 mg once daily) for up to 10 days or to receive usual care alone. The primary outcome was 28-day mortality. Here, we report the preliminary results of this comparison. Results A total of 2104 patients were assigned to receive dexamethasone and 4321 to receive usual care. Overall, 482 patients (22.9%) in the dexamethasone group and 1110 patients (25.7%) in the usual care group died within 28 days after randomization (age-adjusted rate ratio, 0.83; 95% confidence interval [CI], 0.75 to 0.93; P<0.001). The proportional and absolute between-group differences in mortality varied considerably according to the level of respiratory support that the patients were receiving at the time of randomization. In the dexamethasone group, the incidence of death was lower than that in the usual care group among patients receiving invasive mechanical ventilation (29.3% vs. 41.4%; rate ratio, 0.64; 95% CI, 0.51 to 0.81) and among those receiving oxygen without invasive mechanical ventilation (23.3% vs. 26.2%; rate ratio, 0.82; 95% CI, 0.72 to 0.94) but not among those who were receiving no respiratory support at randomization (17.8% vs. 14.0%; rate ratio, 1.19; 95% CI, 0.91 to 1.55). Conclusions In patients hospitalized with Covid-19, the use of dexamethasone resulted in lower 28-day mortality among those who were receiving either invasive mechanical ventilation or oxygen alone at randomization but not among those receiving no respiratory support. (Funded by the Medical Research Council and National Institute for Health Research and others; RECOVERY ClinicalTrials.gov number, NCT04381936; ISRCTN number, 50189673.)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found

            Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy

            In December 2019, a novel coronavirus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) emerged in China and has spread globally, creating a pandemic. Information about the clinical characteristics of infected patients who require intensive care is limited.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A global clinical measure of fitness and frailty in elderly people.

              There is no single generally accepted clinical definition of frailty. Previously developed tools to assess frailty that have been shown to be predictive of death or need for entry into an institutional facility have not gained acceptance among practising clinicians. We aimed to develop a tool that would be both predictive and easy to use. We developed the 7-point Clinical Frailty Scale and applied it and other established tools that measure frailty to 2305 elderly patients who participated in the second stage of the Canadian Study of Health and Aging (CSHA). We followed this cohort prospectively; after 5 years, we determined the ability of the Clinical Frailty Scale to predict death or need for institutional care, and correlated the results with those obtained from other established tools. The CSHA Clinical Frailty Scale was highly correlated (r = 0.80) with the Frailty Index. Each 1-category increment of our scale significantly increased the medium-term risks of death (21.2% within about 70 mo, 95% confidence interval [CI] 12.5%-30.6%) and entry into an institution (23.9%, 95% CI 8.8%-41.2%) in multivariable models that adjusted for age, sex and education. Analyses of receiver operating characteristic curves showed that our Clinical Frailty Scale performed better than measures of cognition, function or comorbidity in assessing risk for death (area under the curve 0.77 for 18-month and 0.70 for 70-month mortality). Frailty is a valid and clinically important construct that is recognizable by physicians. Clinical judgments about frailty can yield useful predictive information.
                Bookmark

                Author and article information

                Journal
                Nutrition
                Nutrition
                Nutrition (Burbank, Los Angeles County, Calif.)
                Elsevier Inc.
                0899-9007
                1873-1244
                15 August 2021
                15 August 2021
                : 111449
                Affiliations
                [1 ]From the U.O. Anestesia e Rianimazione II, Ospedale San Carlo Borromeo, ASST Santi Paolo e Carlo – Polo Universitario, Milano, Italy
                [2 ]U.O. Anestesia e Rianimazione I, Ospedale San Paolo, ASST Santi Paolo e Carlo – Polo Universitario, Milano, Italy
                Author notes
                [* ]Corresponding author: dott. Michele Umbrello, U.O. Anestesia e Rianimazione II, Ospedale San Carlo Borromeo, ASST Santi Paolo e Carlo – Polo Universitario, Via Pio II, 3 20153 Milano, Italy
                Article
                S0899-9007(21)00311-7 111449
                10.1016/j.nut.2021.111449
                8364677
                34583135
                5c618296-ff3d-49a7-a897-575cce74b17c
                © 2021 Elsevier Inc. All rights reserved.

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                : 20 June 2021
                : 31 July 2021
                : 10 August 2021
                Categories
                Article

                Nutrition & Dietetics
                muscle ultrasound,diaphragm ultrasound,covid-19
                Nutrition & Dietetics
                muscle ultrasound, diaphragm ultrasound, covid-19

                Comments

                Comment on this article